KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Total Debt (2019 - 2025)

Historic Total Debt for Evolent Health (EVH) over the last 7 years, with Q3 2025 value amounting to $1.1 billion.

  • Evolent Health's Total Debt rose 7675.45% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 7675.45%. This contributed to the annual value of $662.0 million for FY2024, which is 1087.65% up from last year.
  • As of Q3 2025, Evolent Health's Total Debt stood at $1.1 billion, which was up 7675.45% from $820.6 million recorded in Q2 2025.
  • Over the past 5 years, Evolent Health's Total Debt peaked at $1.1 billion during Q3 2025, and registered a low of $215.7 million during Q4 2021.
  • Moreover, its 5-year median value for Total Debt was $597.9 million (2024), whereas its average is $522.5 million.
  • Its Total Debt has fluctuated over the past 5 years, first tumbled by 2560.33% in 2021, then skyrocketed by 12373.73% in 2023.
  • Quarter analysis of 5 years shows Evolent Health's Total Debt stood at $215.7 million in 2021, then skyrocketed by 91.48% to $413.0 million in 2022, then skyrocketed by 44.57% to $597.0 million in 2023, then grew by 10.88% to $662.0 million in 2024, then surged by 60.11% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $820.6 million for Q2 2025, and $819.3 million during Q1 2025.